Fauci Confident Johnson & Johnson Vaccine Will Return

Fauci Confident Johnson & Johnson Vaccine Will Return

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

A CDC panel is reviewing the Johnson & Johnson vaccine after a pause was recommended due to rare blood clotting cases. The pause aims to gather more data and ensure proper treatment. Public hesitancy has increased, and some governors criticize the pause for affecting vaccination efforts. Despite this, Dr. Fauci remains confident that the vaccine will be approved for use with certain precautions. The US is experiencing a rise in COVID-19 cases, with a seven-day average of 70,000 daily cases.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the primary reason for the CDC panel's evaluation of the Johnson & Johnson vaccine?

To increase the vaccine's production

To reduce vaccine costs

To promote international distribution

To address blood clotting concerns

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How did the pause on the J&J vaccine affect public perception?

It increased confidence in the vaccine

It had no impact on public perception

It led to a decline in public confidence

It caused a surge in vaccine demand

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the reaction of some governors to the pause on the J&J vaccine?

They supported the pause

They believed it harmed vaccination efforts

They were indifferent to the pause

They called for a complete halt of all vaccines

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is Dr. Fauci's stance on the future use of the J&J vaccine?

He thinks it should be used without restrictions

He suggests it should be replaced by another vaccine

He is confident it will be used with caution

He believes it should be discontinued

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the expected outcome from the CDC panel regarding the J&J vaccine?

A recommendation for global distribution

A complete ban on the vaccine

Approval with specific precautions

Immediate resumption without changes